X

Annual Medicare preventative exams now include review of opioid use



September 27, 2018
Area(s) of Interest: Drug Prescribing/Dispensing Public Payors 

On August 28, the Centers for Medicare and Medicaid Services (CMS) published an update to the Initial Preventive Physician Examination and Annual Wellness Visit benefits, highlighting that a review of patient opioid use is now a component of medical and social history assessments.

Per CMS, the review of opioid use during these annual preventative exams will help physicians identify patients using opioids, discuss alternative for non-opioid pain therapies, and assist in diagnosing and treatment for patients experiencing or at risk for opioid-use disorders.

Additional CMS Resources

CMA Safe Prescribing Resources

The California Medical Association (CMA) supports a well-balanced approach to opioid prescribing and treatment that considers the unique needs of individual patients. CMA’s safe prescribing resource page includes the most current information and resources on prescribing controlled substances safely and effectively to relieve pain, while simultaneously reducing the risk of prescription medication misuse, addiction and overdose. There you will find:

Resources on prescribing controlled substances safely and effectively to relieve pain, while simultaneously reducing the risk of prescription medication misuse, addiction and overdose

  • CMA’s white papers on prescribing opioids
  • Links to relevant documents in CMA’s health law library
  • Continuing medical education courses and webinars
  • Current information on the state's prescription drug monitoring database

Join CMA Today!

Explore why over 43,000 California physicians have joined CMA to advocate for patients, the medical profession and the future of health care.

Was this page helpful?